Psychosocial and medical histories of stimulant-treated children.

PubWeight™: 1.46‹?› | Rank: Top 5%

🔗 View Article (PMID 2904428)

Published in J Am Acad Child Adolesc Psychiatry on November 01, 1988

Authors

P S Jensen, R E Shervette, S N Xenakis, M W Bain

Articles citing this

Rate and predictors of divorce among parents of youths with ADHD. J Consult Clin Psychol (2008) 1.43

Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. Child Adolesc Psychiatry Ment Health (2008) 1.37

Overview of Attention Deficit Hyperactivity Disorder in Young Children. Health Psychol Res (2015) 0.77

Zero divorce rate--too good to be true. J Am Acad Child Adolesc Psychiatry (1989) 0.75

Articles by these authors

The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry (1996) 8.16

Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet (1998) 5.34

Coming to terms with the terms of risk. Arch Gen Psychiatry (1997) 3.98

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87

Criterion validity of the NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3). J Am Acad Child Adolesc Psychiatry (1996) 3.24

Age and gender differences in oppositional behavior and conduct problems: a cross-sectional household study of middle childhood and adolescence. J Abnorm Psychol (2000) 2.45

The NIMH Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study: background and methodology. J Am Acad Child Adolesc Psychiatry (1996) 2.43

Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol (2000) 2.36

Lowering the burden of suffering from child psychiatric disorder: trade-offs among clinical, targeted, and universal interventions. J Am Acad Child Adolesc Psychiatry (1998) 2.29

Validity of DSM-IV subtypes of conduct disorder based on age of onset. J Am Acad Child Adolesc Psychiatry (1998) 1.96

Bipolar affective disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry (1995) 1.93

Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. J Abnorm Child Psychol (2000) 1.81

Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol (2000) 1.76

Symptom profiles in children with ADHD: effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry (2001) 1.76

Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry (2001) 1.63

Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry (1996) 1.58

Father absence: effects on child and maternal psychopathology. J Am Acad Child Adolesc Psychiatry (1989) 1.55

Arteriohepatic dysplasia: a benign syndrome of intrahepatic cholestasis with multiple organ involvement. Ann Intern Med (1979) 1.48

Social context in developmental psychopathology: recommendations for future research from the MacArthur Network on Psychopathology and Development. The MacArthur Foundation Research Network on Psychopathology and Development. Dev Psychopathol (1998) 1.42

Resolved: military family life is hazardous to the mental health of children. J Am Acad Child Adolesc Psychiatry (1992) 1.40

Efficacy and effectiveness of child and adolescent psychotherapy and pharmacotherapy. Ment Health Serv Res (1999) 1.37

National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry (1997) 1.35

Outcomes of mental health care for children and adolescents: I. A comprehensive conceptual model. J Am Acad Child Adolesc Psychiatry (1996) 1.32

Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry (2001) 1.29

Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). J Abnorm Child Psychol (2000) 1.28

Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry (2001) 1.25

Adverse life events and resilience. J Am Acad Child Adolesc Psychiatry (1998) 1.20

NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. J Am Acad Child Adolesc Psychiatry (1995) 1.18

Relationship between specific adverse life events and psychiatric disorders. J Abnorm Child Psychol (2001) 1.15

Anxiety and depressive disorders in attention deficit disorder with hyperactivity: new findings. Am J Psychiatry (1993) 1.08

Medication management of stimulants in pediatric practice settings: a national perspective. J Dev Behav Pediatr (2000) 1.07

Childhood obsessive-compulsive disorder in the NIMH MECA study: parent versus child identification of cases. Methods for the Epidemiology of Child and Adolescent Mental Disorders. J Anxiety Disord (2002) 1.06

Arteriohepatic dysplasia: radiologic features of a new syndrome. AJR Am J Roentgenol (1980) 1.04

The doctor-patient relationship: headed for impasse or improvement? Ann Intern Med (1981) 1.02

Child psychopathology rating scales and interrater agreement: I. Parents' gender and psychiatric symptoms. J Am Acad Child Adolesc Psychiatry (1988) 1.00

Features of interviews questions associated with attenuation of symptom reports. J Abnorm Child Psychol (1999) 0.99

Child psychopathology rating scales and interrater agreement: II. Child and family characteristics. J Am Acad Child Adolesc Psychiatry (1988) 0.98

Strand specificity of the topoisomerase II mediated double-stranded DNA cleavage reaction. Biochemistry (1989) 0.98

Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage. Cancer Res (1990) 0.98

Hemophilic pseudotumor. Diagnosis, treatment, and complications. Am J Dis Child (1975) 0.98

How specific is specific impairment? J Am Acad Child Adolesc Psychiatry (2000) 0.96

Medication development and testing in children and adolescents. Current problems, future directions. Arch Gen Psychiatry (1997) 0.95

Major depression and dysthymia in children and adolescents: discriminant validity and differential consequences in a community sample. J Am Acad Child Adolesc Psychiatry (2000) 0.94

Jimson "loco" weed abuse in adolescents. Pediatrics (1979) 0.92

Radiology of postnatal skeletal development. II. The manubrium and sternum. Skeletal Radiol (1979) 0.91

A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyroidism. J Clin Endocrinol Metab (1983) 0.90

The military family in review: context, risk, and prevention. J Am Acad Child Psychiatry (1986) 0.88

Risk, protective factors, and supportive interventions in chronic airway obstruction. Arch Gen Psychiatry (1983) 0.88

Quantification of colour Doppler activity in the wrist in patients with rheumatoid arthritis--the reliability of different methods for image selection and evaluation. Ultraschall Med (2008) 0.86

Diagnosis and treatment of attention deficit disorder in two general hospital clinics. Hosp Community Psychiatry (1989) 0.86

Hemochromatosis: a disease often silent but not invisible. AJR Am J Roentgenol (1976) 0.85

Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II. Cancer Res (1991) 0.85

Stimulation of topoisomerase II mediated DNA cleavage at specific sequence elements by the 2-nitroimidazole Ro 15-0216. Biochemistry (1990) 0.84

Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis. Clin Ther (2001) 0.84

Developmental perspectives in pediatric psychopharmacology. Psychopharmacol Bull (1995) 0.81

Ultrasound Doppler score correlates with OMERACT RAMRIS bone marrow oedema and synovitis score in the wrist joint of patients with rheumatoid arthritis. Ultraschall Med (2011) 0.81

[Ambulatory psychiatry--a follow-up after 1 year]. Ugeskr Laeger (1993) 0.81

Current concepts with respect to chondrocalcinosis and the pseudogout syndrome. Am J Roentgenol Radium Ther Nucl Med (1975) 0.81

No correlation between body mass index and striatal dopamine transporter availability in healthy volunteers using SPECT and [123I]PE2I. Obesity (Silver Spring) (2013) 0.80

Introduction. Current issues in childhood bipolarity. J Affect Disord (1998) 0.79

The "military family syndrome" revisited: "by the numbers". J Nerv Ment Dis (1991) 0.79

Fibrogenesis imperfecta ossium with early onset: observations after 20 years of illness. Bone (1986) 0.79

Data-gathering tools for "real world" clinical settings: a multisite feasibility study. J Am Acad Child Adolesc Psychiatry (1996) 0.78

Manual development for the treatment of child and adolescent disorders. Psychopharmacol Bull (1997) 0.78

Bone mineral analysis using single-energy computed tomography. Invest Radiol (1979) 0.78

Assessment of bone mass in the radius by computed tomography. AJR Am J Roentgenol (1980) 0.77

Chronic psychosis in epilepsy. A clinical investigation of 29 patients. Acta Psychiatr Scand (1982) 0.77

In-situ SEM microchip setup for electrochemical experiments with water based solutions. Ultramicroscopy (2013) 0.77

Munchausen syndrome by proxy: 1990. A portent for problems? Clin Pediatr (Phila) (1991) 0.76

Integrating science and ethics in child and adolescent psychiatry research. Biol Psychiatry (1999) 0.75

Toward clinically relevant clinical trials. Psychopharmacol Bull (1997) 0.75

Antagonistic effect of aclarubicin on camptothecin induced cytotoxicity: role of topoisomerase I. Biochem Pharmacol (1994) 0.75

Case report of conversion catatonia: indication for hypnosis. Am J Psychother (1984) 0.75

Drug Stimulated DNA Cleavage Mediated by Cauliflower Topoisomerase II. Plant Physiol (1991) 0.75

Chronic treatment of Paget's disease of bone with synthetic human calcitonin. Yale J Biol Med (1982) 0.75

Debate: the effects of military life on children. J Am Acad Child Adolesc Psychiatry (1993) 0.75

Dealing with the stress of an HIV-positive diagnosis at an Army medical center. Mil Med (1990) 0.75

[DANO (amitriptyline-N-oxide). A new antidepressive agent. A study with special reference to cardiotoxic effect]. Nord Psykiatr Tidsskr (1969) 0.75

A triage and emergency treatment model for combat medics on the chemical battlefield. Mil Med (1985) 0.75

[Thiothixene (Navane). A new neuroleptic drug]. Nord Psykiatr Tidsskr (1969) 0.75

Cystadenolymphoma (Warthin's tumour) of the parotid gland. A clinical and histological evaluation of 40 cases. Scand J Plast Reconstr Surg (1970) 0.75

Therapists' actions that influence their perceptions of "good" psychotherapy sessions. J Nerv Ment Dis (1983) 0.75

[Mucous membrane pemphigoid with oral manifestations]. Ugeskr Laeger (1967) 0.75

Prevalence of type A behavior in American combat soldiers and their children. Mil Med (1988) 0.75

[On hemorrhagic diathesis with reference to its oral aspects]. Tandlaegebladet (1967) 0.75

[Oral candidosis. A review of the literature and a retrospective study of 91 patients]. Ugeskr Laeger (1969) 0.75

Health problems among Army children. Mil Med (1992) 0.75

Psychological reactions during chemical warfare training. Mil Med (1983) 0.75

[Mucous membrane pemphigoid with oral manifestations]. Tandlaegebladet (1968) 0.75

[Oral aspects in leukopenia. 4 representative cases]. Tandlaegebladet (1969) 0.75

Group psychotherapy in the treatment of adolescent and preadolescent military dependents with recurrent diabetic ketoacidosis. Mil Med (1990) 0.75